Tous Actualités
Suivre
Abonner LifeWatch AG

LifeWatch AG

EANS-Adhoc: LifeWatch receives Swiss Equity Award for successful corporate development Swiss Equity Conference presents first prize to LifeWatch

  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
Company Information
16.09.2009
Neuhausen am Rheinfall / Switzerland, September 16, 2009 - At the 
Swiss Equity Conference in Zurich, LifeWatch AG (SIX Swiss Exchange: 
LIFE), the leading provider of wireless cardiac monitoring services 
in the U.S., was awarded the first prize for excellent corporate 
development in the most difficult economic times.
There are only a few Swiss small and mid-cap companies which have 
delivered an excellent performance even in the most difficult times 
like these. According to the jury of the Swiss Equity Award, 
LifeWatch is one such company. The jury presented LifeWatch AG´s 
Management with the first prize at this year´s Swiss Equity 
conference. LifeWatch received the award based on its share price 
development from September 1, 2008, (10.00 CHF) leading up to August 
31, 2009, (17.95 CHF) and votes cast by analysts and professional 
investors. All companies listed on the Swiss Market Index SMI, 
excluding Swiss large caps, were eligible for the award.
About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am 
Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is 
the leading healthcare technology and solution company, specializing 
in advanced telehealth systems and wireless cardiac monitoring 
services. LifeWatch services treat high-risk and chronically ill 
patients, health conscious consumers and wellness programs. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the 
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent 
company of LifeWatch Services Inc., a leading US-based cardiac 
monitoring service provider, and manufacturer of telecardiology 
products. www.lifewatch.com
Sign-up for customized e-mail alerts and documentation requests is 
available at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking  statements.  All  
statements  other than statements of historical facts contained in 
this press  release,  including statements regarding future results 
of operations and financial position, business strategy and plans and
objectives for future operations,  are forward-looking statements. 
The  words  "believe,"  "may,"  "will,"  "estimate," "continue,"  
"anticipate,"  "intend,"  "expect"  and  similar  expressions   are 
intended to identify forward-looking statements. LifeWatch AG  has  
based  these forward looking statements  largely  on  current  
expectations  and  projections about future events and  financial  
trends  that  it  believes  may  affect  the financial condition, 
results of operations, business strategy,  short  term  and long term
business  operations  and  objectives,  and  financial  needs.  These
forward-looking statements are subject to a number of risks,  
uncertainties  and assumptions. In  light  of  these  risks,  
uncertainties  and  assumptions,  the forward-looking events and 
circumstances described  may  not  occur  and  actual results could 
differ materially and adversely from those anticipated or  implied in
the forward-looking statements.  All  forward-looking  statements  
are  based only on data available to LifeWatch AG at the time of the 
issue  of  this  press release. LifeWatch AG does not undertake any 
obligation to update  any  forward- looking  statements  contained  
in  this  press  release  as  a  result  of  new information, future 
events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN  THE  UNITED  STATES  OF  
AMERICA  AND SHOULD NOT BE DISTRIBUTED TO  UNITED  STATES  PERSONS  
OR  PUBLICATIONS  WITH  A GENERAL  CIRCULATION  IN  THE  UNITED  
STATES.  THIS  PRESS  RELEASE  DOES   NOT CONSTITUTE AN OFFER OF 
SECURITIES OF LIFEWATCH AG OR  ANY  OF  ITS  SUBSIDIARIES FOR SALE IN
THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE  ANY 
SECURITIES OF LIFEWATCH  AG  OR  ITS  SUBSIDIARIES  IN  THE  UNITED  
STATES.  IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND  ITS  
SUBSIDIARIES  HAVE  NOT  BEEN REGISTERED UNDER THE UNITED STATES 
SECURITIES LAWS AND MAY NOT BE OFFERED,  SOLD OR DELIVERED WITHIN THE
UNITED STATES OR TO  U.S.  PERSONS  ABSENT  REGISTRATION UNDER OR AN 
APPLICABLE EXEMPTION  FROM  THE  REGISTRATION  REQUIREMENTS  OF  THE 
UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO 
BE  MADE  IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS 
THAT  MAY  BE  OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS 
APPLICABLE, AND WILL CONTAIN  DETAILED INFORMATION ABOUT THE ISSUER 
AND ITS MANAGEMENT AS WELL AS FINANCIAL  STATEMENTS OF THE ISSUER.
Press Release
September 16, 2009

Further inquiry note:

For further information from LifeWatch please contact:
Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | E-mail kobibe@lifewatch.com

Sensus Investor & Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade

Plus de actualités: LifeWatch AG
Plus de actualités: LifeWatch AG